Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant.

Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, Amara A, Baleux F, Portier A, Galanaud P, Emilie D.

Blood. 2002 Jan 15;99(2):427-36.


Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes.

Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, Couderc J, Galanaud P, Emilie D.

Eur J Immunol. 2001 Feb;31(2):350-9.


Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.

Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D.

J Immunol. 2003 Mar 15;170(6):3392-400.


Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.

Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N.

Ophthalmology. 2003 Feb;110(2):421-6.


The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.

Aboumrad E, Madec AM, Thivolet C.

Clin Exp Immunol. 2007 Jun;148(3):432-9. Epub 2007 Mar 21.


Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development.

Hernández-López C, Varas A, Sacedón R, Jiménez E, Muñoz JJ, Zapata AG, Vicente A.

Blood. 2002 Jan 15;99(2):546-54.


[Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].

Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT.

Zhonghua Yi Xue Za Zhi. 2008 Jan 15;88(3):202-5. Chinese.


Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.

Corcione A, Ottonello L, Tortolina G, Facchetti P, Airoldi I, Guglielmino R, Dadati P, Truini M, Sozzani S, Dallegri F, Pistoia V.

J Natl Cancer Inst. 2000 Apr 19;92(8):628-35.


Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus.

Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, Kitabatake M, Hontsu S, Ezaki T, Kimura H, Matsushima K.

J Immunol. 2004 Mar 15;172(6):3628-34.


SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells.

Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE.

Stem Cells. 2005 Oct;23(9):1324-32. Erratum in: Stem Cells. 2006 Jan;24(1):211.


Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases.

Armengol MP, Cardoso-Schmidt CB, Fernández M, Ferrer X, Pujol-Borrell R, Juan M.

J Immunol. 2003 Jun 15;170(12):6320-8.


Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.

Gouwy M, Struyf S, Catusse J, Proost P, Van Damme J.

J Leukoc Biol. 2004 Jul;76(1):185-94. Epub 2004 Apr 9.


Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E.

Brain. 2006 Jan;129(Pt 1):200-11. Epub 2005 Nov 9.


The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor.

Egawa T, Kawabata K, Kawamoto H, Amada K, Okamoto R, Fujii N, Kishimoto T, Katsura Y, Nagasawa T.

Immunity. 2001 Aug;15(2):323-34.


A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo.

Ara T, Itoi M, Kawabata K, Egawa T, Tokoyoda K, Sugiyama T, Fujii N, Amagai T, Nagasawa T.

J Immunol. 2003 May 1;170(9):4649-55.


Supplemental Content

Support Center